- Home
- JLS vs OPRX Comparison
JLS vs OPRX Comparison
Compare JLS & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JLS | OPRX |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.6M | 117.1M |
| IPO Year | 2009 | 2008 |
Fundamental Metrics
Financial Performance| Metric | JLS | OPRX |
|---|---|---|
| Price | $17.26 | $6.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 21.3K | ★ 301.7K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 9.33% | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $17.19 | $4.54 |
| 52 Week High | $19.09 | $22.25 |
Technical Indicators
Market Signals| Indicator | JLS | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 56.91 |
| Support Level | N/A | $6.03 |
| Resistance Level | $18.68 | $6.93 |
| Average True Range (ATR) | 0.18 | 0.24 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 28.28 | 48.47 |
Price Performance
Historical ComparisonAbout JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. The Fund's investment objective is to provide a high level of current income.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.